STAMBPL1

Across TCGA pan-cancer cohorts, STAMBPL1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated STAMBPL1 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher STAMBPL1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated STAMBPL1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.

CCRCC, UCEC, and HNSC are the cancer types where STAMBPL1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	II,III,IV	0.986	0.761	.003	39	view →
UCEC	OS	Quartile	All	0.765	1.000	.003	34	view →
HNSC	DFS	Tertile	II,III,IV	0.910	1.000	.016	10	view →
PDAC	OS	Quartile	III,IV	0.835	0.241	.008	5	view →
LSCC	DFS	Tertile	II,III,IV	0.411	0.765	.021	4	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

STAMBPL1–CCRCC (DFS)

Open the CCRCC breakdown →